Diabetes and infection: assessing the association with glycaemic control in population-based studies (Q38666111)

5 September 2017

Diabetes and infection: assessing the association with glycaemic control in population-based studies (English)

1 reference

5 September 2017

Tess Harris

3

0 references

Julia A Critchley

object named as

Julia Critchley

5

0 references

author name string

Jonathan Pearson-Stuttard

1

1 reference

PubMed ID

26656292

5 September 2017

Samkeliso Blundell

2

1 reference

PubMed ID

26656292

5 September 2017

Derek G Cook

4

1 reference

5 September 2017

2 December 2015

1 reference

The Lancet: Diabetes & Endocrinology

5 September 2017

1 reference

5 September 2017

4

1 reference

5 September 2017

148-158

1 reference

5 September 2017

2

1 reference

Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988-2010

5 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Prevalence of diabetes in care home residents

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Infections in diabetes mellitus and hyperglycemia.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Pulmonary mucormycosis: the last 30 years

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Quantifying the risk of infectious diseases for people with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes is rising in OECD countries, report warns

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diab

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes mellitus, fasting glucose, and risk of cause-specific death

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Adverse events and their association with treatment regimens in the diabetes control and complications trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD)

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Dysglycaemia, vasculopenia, and the chronic consequences of diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Effects of intensive glucose lowering in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Type 2 Diabetes and Pneumonia Outcomes: A population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Effect of acute hyperglycaemia and/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Impaired phagocytosis by alveolar macrophages from diabetic rats is related to the deficient coupling of LTs to the Fc gamma R signaling cascade.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

The impact of diabetes in patients with necrotizing soft tissue infections

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes and the severity of pandemic influenza A (H1N1) infection

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes and infection: is there a link?--A mini-review.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Infections in patients with type 2 diabetes in general practice.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes and the risk of acute urinary tract infection among postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Effect of insulin therapy on quality of life in Type 2 diabetes mellitus: The Fremantle Diabetes Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Risk of recurrent acute lower urinary tract infections and prescription pattern of antibiotics in women with and without diabetes in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Severe bloodstream infections: a population-based assessment

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

The use of primary care databases: case-control and case-only designs

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Management of diabetes in resource-poor settings.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and Diabetes Mellitus, HIV and Metabolic Syndrome, and the impact of globalization

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes and cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Long-term cognitive impairment and functional disability among survivors of severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Bidirectional relationship between cognitive function and pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900379-4

7 January 2021

10.1016/S2213-8587(15)00379-4

Identifiers

DOI

1 reference

5 September 2017

1 reference

PubMed ID

26656292